Saturday, 23 March 2019

World News

  • Dicerna announces start of Ph1 clinical trial of DCR-HBVS

    World |  News | 0 Comment | 29 Jan, 2019

    Dicerna Pharmaceuticals, a leading developer of RNA interference (RNAi) therapeutics, today announced the dosing of the first human volunteer in its Phase 1 clinical trial of DCR-HBVS, the ...Read more

  • Intensive lowering of blood pressure can have a measurable impact on MCI, says a NIH research

    World |  News | 0 Comment | 29 Jan, 2019

    Intensive lowering of blood pressure did not significantly reduce dementia risk but did have a measurable impact on mild cognitive impairment (MCI), according to the final, peer-reviewed re...Read more

  • G-CON collaborates with GE Healthcare

    World |  News | 0 Comment | 29 Jan, 2019

    G-CON Manufacturing, the leader in prefabricated flexible cleanroom solutions and GE Healthcare plan to collaborate to improve cell therapy and viral vector manufacturing by providing drug ...Read more

  • J&J announces USFDA approval of IMBRUVICA

    World |  News | 0 Comment | 29 Jan, 2019

    The Janssen Pharmaceutical Companies of Johnson & Johnson has announced the U.S. Food and Drug Administration (FDA) approval of IMBRUVICA® (ibrutinib) in combination with obinu...Read more

  • Abcam acquires Calico Labs

    World |  News | 0 Comment | 28 Jan, 2019

    Abcam, a global innovator in life science reagents and tools has announced its acquisition of Calico Biolabs, a developer of custom high-quality recombinant rabbit monoclonal antibodies for...Read more

  • Roya.com partners with Compliancy Group

    World |  News | 0 Comment | 28 Jan, 2019

    Roya.com is pleased to announce a new Partnership with Compliancy Group offering medical professionals HIPAA Compliant, AMP powered custom websites Roya.com, an industry leader for custom ...Read more

  • Torque announces new appointments

    World |  News | 0 Comment | 28 Jan, 2019

    Torque, an immuno-oncology company developing first-in-class Deep-Primed T Cell Therapeutics to direct immune power deep within the tumor microenvironment has announced the appointment of J...Read more

  • DZD completes $8.6M series A round

    World |  News | 0 Comment | 28 Jan, 2019

    US based start-up, Day Zero Diagnostics, Inc. (DZD) which is an infectious disease diagnostic company using genome sequencing and machine learning to enable rapid and precise treatment in a...Read more

  • The BHF call for proposals under Big Beat Challenge

    World |  News | 0 Comment | 25 Jan, 2019

    The British Heart Foundation (BHF) is calling for researchers and innovators from around the world to apply for one of the largest research grants of its kind in history.  The ch...Read more

  • Merck enters into an exclusive licensing agreement with Vertex

    World |  News | 0 Comment | 25 Jan, 2019

    Merck, a leading science and technology company has announced that it has entered into an exclusive licensing agreement with Vertex Pharmaceuticals Incorporated, Boston, USA for two DNA-dep...Read more

  • deCODE publishes the first genetic map of the Human Genome

    World |  News | 0 Comment | 25 Jan, 2019

    Scientists at deCODE genetics in Iceland, a subsidiary of Amgen has published the first genetic map of the human genome developed using whole-genome sequence data. The map provides the most...Read more

  • NIH collaborates with AAS and Bill & Melinda Gates

    World |  News | 0 Comment | 25 Jan, 2019

    NIH, the African Academy of Sciences, and the Bill & Melinda Gates Foundation are collaborating to establish the African Postdoctoral Training Initiative. Ten African scientists have b...Read more

  • Eppendorf & Science Prize for Neurobiology 2019: Call for Entries!

    World |  News | 0 Comment | 25 Jan, 2019

    Eppendorf and the journal Science are now accepting applications for the 2019 Eppendorf & Science Prize for Neurobiology. This annual international research prize of US$25,000 is award...Read more

  • Alvotech raises $300mn to further biosimilar development

    World |  News | 0 Comment | 24 Jan, 2019

    Alvotech has successfully raised US$300 million through a private bond offering. Net proceeds from the capital raised will be used to fuel continued growth, refinance of existing debt and...Read more

  • Philogen signs drug discovery contract with J & J

    World |  News | 0 Comment | 24 Jan, 2019

    Philogen S.p.A., a privately-owned biotechnology company, has announced through its wholly-owned Swiss subsidiary, Philochem AG, a collaboration agreement with Janssen Biotech, Inc., one of...Read more

  • SSB offers services for characterization of NBEs

    World |  News | 0 Comment | 24 Jan, 2019

    Sartorius Stedim Biotech (SSB), a leading international supplier for the biopharmaceutical industry, announced the launch of services for new biological entities, called NBE Product Charact...Read more

  • Vertex announces EC approval for ORKAMBI

    World |  News | 0 Comment | 24 Jan, 2019

    Global Biotechnology company, Vertex Pharmaceuticals has announced that the European Commission has granted approval of the label extension for ORKAMBI (lumacaftor/ivacaftor) for the treatm...Read more

  • Attune Pharma announces $23M Series B Financing

    World |  News | 0 Comment | 24 Jan, 2019

    Clinical Stage biotech company, Attune Pharmaceuticals focused on the discovery and development of novel, orally administered, small molecule therapeutics for the treatment of rare diseases...Read more

Podcast

 

Survey Box

Are policy innovations key to address the healthcare challenges in Asia?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls